The Patent Finder

Immundiagnostik AG

Also on record
Records under this name other than the patents Immundiagnostik AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 14 patents it holds.

Showing 1 to 6 of 6 · Back to Immundiagnostik AG

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,842,851Relaxin for Treating Patients Afflicted of Impaired Glucose Tolerance
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,226,512Method for Treating Heart Failure with Preserved Ejection Fraction by Administering Human RELAXIN-2
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,714,082Method for determination of members of the S100 family of calcium binding proteins by immunoturbidimetry
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 7,851,163Method for determining the biologically effective parathyroid hormone activity in a sample
Lapsed on the fee record
Ended Dec 14, 2022 · USPTO record
Lapsed on the fee recordEnded Dec 14, 2022USPTO record
US 8,133,694Functional vitamin D derivatives and method of determining 25-hydroxy- and 1α, 25-dihydroxy vitamin D
Term ended
Term ended Jul 1, 2021 · USPTO record
Term endedTerm ended Jul 1, 2021USPTO record
US 6,787,660Functional vitamin D derivatives and a method for determining 25-hydroxy-vitamin D and 1&agr;, dihydroxy-vitamin D
Term ended
Term ended Feb 20, 2021 · USPTO record
Term endedTerm ended Feb 20, 2021USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited